clinafloxacin

clinafloxacin

Antibiotics A broad-spectrum–gram-negative bacilli, staphylococci fluoroquinolone antibiotic with ↑ activity against streptococci and anaerobes; it is also active against PCP and toxoplasmosis Adverse effects Diarrhea due to Clostridium difficile overgrowth. See Fluoroquinolone.
References in periodicals archive ?
A significant increase in CDAD occurred with imipenem/cilastatin compared with clinafloxacin for empiric treatment of febrile neutropenia (40).
Efficiacy of moxifloxacin, trovafloxacin, clinafloxacin, and levofloxacin against intracellular Legionella pneumophila.
In a prospective multicenter trial, clinafloxacin was effective in 87% of 53 patients with native valve infection (NVE), and 69% of 13 patients with prosthetic valve endocarditis (PVE).
Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
When approved, clinafloxacin will be the most potent antibiotic available in the U.
0 [micro]g/mL; grepafloxacin, 32 [micro]g/mL; clinafloxacin, 2.
Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Food and Drug Administration for clinafloxacin, a potent antibiotic therapy and FemHRT, a combination estrogen progestin hormone replacement therapy for menopausal symptoms.
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.
clinafloxacin, a quinolone class anti-infective whose anti- microbial activity is considered remarkable.